GANX icon

Gain Therapeutics
GANX

Overview Fund Activity

25 hedge funds and large institutions have $7.68M invested in Gain Therapeutics in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+6
Holders Change %
+31.58%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
2
Closed
4
Calls
$47K
Puts
$23K
Net Calls
+$24K
Net Calls Change
+$6K

Top Buyers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$198K
2
Morgan Stanley
2
Morgan Stanley
New York
$191K
3
Cambridge Investment Research Advisors
3
Cambridge Investment Research Advisors
Iowa
$118K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$101K
5
Jones Financial Companies
5
Jones Financial Companies
Missouri
$212K

Top Sellers

1
GAM
1
Gotham Asset Management
New York
$3.74M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$578K
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
Simplex Trading
5
Simplex Trading
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
– -$94.8K -53,264 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– -$8.62K -4,842 Closed
Simplex Trading
28
Simplex Trading
Illinois
– -$8K -4,801 Closed
Group One Trading
29
Group One Trading
Illinois
– -$2.49K -1,401 Closed
1
2